Roberta Diaz Brinton

Dr. Brinton is a world leading neuroscientist in the field of Alzheimer’s disease, and particularly the therapeutic effect of neurosteroids. Her research has focused on the mechanisms by which the aging brain develops late onset Alzheimer’s disease and her insights have formed the basis for programs that are critical to personalized therapeutic care for the disease. Her scientific endeavors have been continuously funded by the National Institutes for Health and have led to two NIH National Institute on Aging funded clinical trials.

Dr. Brinton currently serves on the Board of Governors of the Alzheimer’s Drug Development Foundation (New York). She has served on the NIH Director’s Center for Scientific Review Advisory Council, National Institute of Mental Health Scientific Intramural Review Program Board of Scientific Counselors and the National Institute of Mental Health Blue Ribbon Panel. Currently, she serves on the scientific review boards for the National Institute on Aging Review Panels, the Alzheimer’s Drug Development Foundation and the Alzheimer’s Association. Her professional memberships include the Society for Neuroscience and the International Brain Research Organization/World Federation of Neuroscientists.